Accuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting



MADISON, Wis., Oct. 2, 2023 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) announced today that the company has a 510(k) pending for an online adaptive therapy option*, Cenos™, for its Radixact® System. The solution was unveiled, in partnership with Limbus AI, at the 2023 ASTRO…

Leave a Reply